Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
The Journal of Experimental Medicine
|
July 28, 2019
Combination of quadruplex qPCR and next-generation sequencing for qualitative and quantitative analysis of the HIV-1 latent reservoir
Christian Gaebler, Julio C C Lorenzi, Thiago Y Oliveira, et al.
Nature Medicine
|
February 5, 2020
Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity
Julia Niessl, Amy E Baxter, Pilar Mendoza, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 14, 2018
Relationship between intact HIV-1 proviruses in circulating CD4<sup>+</sup> T cells and rebound viruses emerging during treatment interruption
Ching-Lan Lu, Joy A Pai, Lilian Nogueira, et al.
Journal of Virology
|
December 10, 2020
Neutralizing Activity of Broadly Neutralizing anti-HIV-1 Antibodies against Primary African Isolates
Julio C C Lorenzi, Pilar Mendoza, Yehuda Z Cohen, et al.
Molecular Cancer
|
February 5, 2022
Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia
Alejandro M Hortal, Clara L Oeste, Claudia Cifuentes, et al.
Science Signaling
|
May 31, 2018
R-Ras2 is required for germinal center formation to aid B cells during energetically demanding processes
Pilar Mendoza, Nuria Martínez-Martín, Elena R Bovolenta, et al.
The Journal of Experimental Medicine
|
July 22, 2020
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
Fabian Schmidt, Yiska Weisblum, Frauke Muecksch, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2020
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
Fabian Schmidt, Yiska Weisblum, Frauke Muecksch, et al.
The Journal of Experimental Medicine
|
August 4, 2018
Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117
Yehuda Z Cohen, Julio C C Lorenzi, Lisa Krassnig, et al.
NPJ Vaccines
|
July 6, 2026
Preclinical immunogenicity of the LP.8.1-adapted BNT162b2 COVID-19 vaccine
Chaitanya Kurhade, Wei Chen, Weiqiang Li, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
The Journal of Experimental Medicine
|
July 28, 2019
Combination of quadruplex qPCR and next-generation sequencing for qualitative and quantitative analysis of the HIV-1 latent reservoir
Christian Gaebler, Julio C C Lorenzi, Thiago Y Oliveira, et al.
Nature Medicine
|
February 5, 2020
Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity
Julia Niessl, Amy E Baxter, Pilar Mendoza, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 14, 2018
Relationship between intact HIV-1 proviruses in circulating CD4<sup>+</sup> T cells and rebound viruses emerging during treatment interruption
Ching-Lan Lu, Joy A Pai, Lilian Nogueira, et al.
Journal of Virology
|
December 10, 2020
Neutralizing Activity of Broadly Neutralizing anti-HIV-1 Antibodies against Primary African Isolates
Julio C C Lorenzi, Pilar Mendoza, Yehuda Z Cohen, et al.
Molecular Cancer
|
February 5, 2022
Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia
Alejandro M Hortal, Clara L Oeste, Claudia Cifuentes, et al.
Science Signaling
|
May 31, 2018
R-Ras2 is required for germinal center formation to aid B cells during energetically demanding processes
Pilar Mendoza, Nuria Martínez-Martín, Elena R Bovolenta, et al.
The Journal of Experimental Medicine
|
July 22, 2020
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
Fabian Schmidt, Yiska Weisblum, Frauke Muecksch, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2020
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
Fabian Schmidt, Yiska Weisblum, Frauke Muecksch, et al.
The Journal of Experimental Medicine
|
August 4, 2018
Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117
Yehuda Z Cohen, Julio C C Lorenzi, Lisa Krassnig, et al.
NPJ Vaccines
|
July 6, 2026
Preclinical immunogenicity of the LP.8.1-adapted BNT162b2 COVID-19 vaccine
Chaitanya Kurhade, Wei Chen, Weiqiang Li, et al.
Page
of 3